CME on ReachMD-logo

CME on ReachMD

ReachMD

Providing Medical Knowledge on Demand. Our short format sessions are designed for busy medical professionals and delivered in convenient, easy to use ways. Listen to ReachMD on your computer at ReachMD.com or download and use the ReachMD MedicalRadio iPhone app and earn CME credit at your convenience.

Providing Medical Knowledge on Demand. Our short format sessions are designed for busy medical professionals and delivered in convenient, easy to use ways. Listen to ReachMD on your computer at ReachMD.com or download and use the ReachMD MedicalRadio iPhone app and earn CME credit at your convenience.
More Information

Location:

Fort Washington, PA

Networks:

ReachMD

Description:

Providing Medical Knowledge on Demand. Our short format sessions are designed for busy medical professionals and delivered in convenient, easy to use ways. Listen to ReachMD on your computer at ReachMD.com or download and use the ReachMD MedicalRadio iPhone app and earn CME credit at your convenience.

Language:

English


Episodes

Complex Vaginitis Cases: Applying New Diagnostic Methods to Enhance Patient Outcomes

6/4/2018
More
CME credits: 0.25 Valid until: 05-06-2019 Claim your CME credit at https://reachmd.com/programs/cme/complex-vaginitis-cases-applying-new-diagnostic-methods-to-enhance-patient-outcomes/10156/ Up to 40% of women who suffer from symptoms of vaginitis cannot be diagnosed at the initial office visit, and 25% are placed on a pharmacologic therapy not based on validated diagnostic testing. “Complex Vaginitis Cases: Applying New Diagnostic Methods to Enhance Patient Outcomes” is a case based,...

Duration:00:11:29

Strategies for Improving Outcomes in Patients with Parkinson’s Disease

6/3/2018
More
CME credits: 0.50 Valid until: 04-06-2019 Claim your CME credit at https://reachmd.com/programs/cme/strategies-improving-outcomes-patients-parkinsons-disease/10157/ Parkinson’s disease (PD) affects roughly one million Americans and more than 10 million people worldwide. It is a progressive neurologic disorder characterized by motor and nonmotor symptoms. Key motor symptoms include resting tremor, bradykinesia, rigidity, and postural instability. Nonmotor symptoms include psychosis,...

Duration:00:31:29

Clinical Debates in Multiple Myeloma: Putting Evidence Into Context

5/22/2018
More
CME credits: 1.00 Valid until: 22-05-2019 Claim your CME credit at https://reachmd.com/programs/cme/clinical-debates-multiple-myeloma-putting-evidence-context/10130/ The treatment armamentarium for multiple myeloma (MM) has expanded significantly in recent years, with 6 new agents or indications approved by the US Food & Drug Administration since 2015. Treatment options now include immunomodulatory drugs, proteasome inhibitors, a histone deacetylase inhibitor, and immunotherapies,...

Duration:00:40:00

Beneath the Surface: Psoriatic Arthritis in Dermatology Practice

5/20/2018
More
CME credits: 0.50 Valid until: 21-05-2019 Claim your CME credit at https://reachmd.com/cme/dermatology/beneath-surface-psoriatic-arthritis-dermatology-practice/10134/ Untreated psoriatic arthritis leads to irreversible joint damage. However, most people with psoriatic arthritis experience multiple symptoms over a period of years before they are properly diagnosed. Dermatology providers are at the front lines, making a psoriatic arthritis diagnosis and helping to prevent joint...

Duration:00:24:29

Immunocellular Therapies for Relapsed/Refractory Heme Malignancies: A Focus on CAR T-Cell Therapy

5/14/2018
More
CME credits: 0.25 Valid until: 14-05-2019 Claim your CME credit at https://reachmd.com/programs/cme/immunocellular-therapies-relapsedrefractory-heme-malignancies-focus-car-t-cell-therapy/10113/ The treatment of relapsed or refractory leukemias and lymphomas continues to be challenging, often characterized by limited therapeutic options and poor outcomes. Effective new therapies are needed for these patients. Chimeric antigen receptor (CAR) T-cell therapy represents a radical departure...

Duration:00:15:00

Innovations in Lung Cancer Diagnosis and Surgical Treatment

5/8/2018
More
CME credits: 0.25 Valid until: 09-05-2019 Claim your CME credit at https://reachmd.com/programs/cme/innovations-in-lung-cancer-diagnosis-and-surgical-treatment/9886/ In this segment, Dr. Hennon provides an overview of the importance of screening for lung cancer as well as describes recent developments in the diagnosis and surgical management of lung cancer. This activity is part of a series of in-depth discussions with oncology thought leaders at the Roswell Park Cancer Institute in...

Duration:00:15:00

Pathways in Oncology: Tools to Assure Quality Care

5/6/2018
More
CME credits: 0.25 Valid until: 07-05-2019 Claim your CME credit at https://reachmd.com/programs/cme/pathways-in-oncology-tools-to-assure-quality-care/9890/ In this segment, Dr. Edge discusses the benefits of using clinical oncology pathways in practice as well as their optimal use for patients. Also discussed will be how to best select the primary choice for treatment when using clinical oncology pathways. This activity is part of a series of in-depth discussions with oncology thought...

Duration:00:18:30

Effective Communication: Improving Patient’s Understanding of Cancer Risk

5/6/2018
More
CME credits: 0.25 Valid until: 07-05-2019 Claim your CME credit at https://reachmd.com/programs/cme/effective-communication-improving-patients-understanding-of-cancer-risk/9888/ In this segment, Dr. Reid explains the different ways risk is communicated and how this can affect a patient’s perception as well as the different ways in which one can effectively improve a patient’s understanding of their cancer risk. This activity is part of a series of in-depth discussions with oncology...

Duration:00:09:59

Expert Review of Case Studies for Autoantibody Testing for Autoimmune Diseases

4/26/2018
More
CME credits: 0.75 Valid until: 27-04-2019 Claim your CME credit at https://reachmd.com/programs/cme/expert-review-of-case-studies-for-autoantibody-testing-for-autoimmune-diseases/10104/ This innovative, 45-minute, case-based CME activity features two prominent faculty covering important, timely issues and data related to the detection of autoimmune (AI) disorders. Using case studies, the faculty will explore diagnosis and management strategies to maximize patient care. In addition to...

Duration:00:27:59

Update on Psoriasis and PsA: Best Practices in Dermatology

4/19/2018
More
CME credits: 0.50 Valid until: 20-04-2019 Claim your CME credit at https://reachmd.com/cme/dermatology/update-psoriasis-and-psa-best-practices-dermatology/10100/ Despite numerous advances in treatment for psoriasis and psoriatic arthritis (PsA), many patients continue to experience negative health consequences that could be prevented or improved with optimal evidence-based care. Dermatology, rheumatology, and primary care clinicians can improve outcomes for their patients by increasing...

Duration:00:28:29

Update on Psoriatic Arthritis: Best Practices in Rheumatology

4/19/2018
More
CME credits: 0.50 Valid until: 20-04-2019 Claim your CME credit at https://reachmd.com/cme/rheumatology/update-psoriatic-arthritis-best-practices-rheumatology/10095/ Despite numerous advances in treatment for psoriasis and psoriatic arthritis (PsA), many patients continue to experience negative health consequences that could be prevented or improved with optimal evidence-based care. Dermatology, rheumatology, and primary care clinicians can improve outcomes for their patients by...

Duration:00:28:59

When Cancer Looks Like Something Else: How Does Mutational Profiling Inform the Diagnosis of Myelodysplasia?

4/12/2018
More
CME credits: 0.25 Valid until: 13-04-2019 Claim your CME credit at https://reachmd.com/programs/cme/when-cancer-looks-like-something-else-how-does-mutational-profiling-inform-diagnosis-myelodysplasia/9887/ In this segment, Dr. Griffiths discusses what MDS is and the importance of that, as well as the mutational profiling in normal aging and MDS and distinguishing mutations from disease. This activity is part of a series of in-depth discussions with oncology thought leaders from the...

Duration:00:14:30

Beginning the Menopause Conversation: Treating Its Impactful Symptoms

4/5/2018
More
CME credits: 0.25 Valid until: 06-04-2019 Claim your CME credit at https://reachmd.com/programs/cme/beginning-menopause-conversation-treating-its-impactful-symptoms/10089/ An estimated 40% of women will spend up to one-third of their lives in menopause, experiencing symptoms such as hot flashes, vaginal dryness, problems sleeping, sexual dysfunction, and joint pain. Despite the significant toll these symptoms can have, such as impact on quality of life and relationships, women are...

Duration:00:14:59

Primary Care Update: Autoantibody Testing for Connective Tissue Diseases

3/25/2018
More
CME credits: 0.75 Valid until: 26-03-2019 Claim your CME credit at https://reachmd.com/programs/cme/primary-care-update-autoantibody-testing-for-connective-tissue-diseases/10073/ This innovative, 30-minute, online activity features a Video Expert Dialogue with two prominent faculty covering important, timely issues and data related to the detection of autoimmune (AI) disorders. The emphasis is on the unique role primary care providers play in diagnosing and managing AI and maximizing...

Duration:00:29:30

Opioid-Based Pain Management: Barriers, Guidelines, and Best Practices

3/22/2018
More
CME credits: 0.25 Valid until: 23-03-2019 Claim your CME credit at https://reachmd.com/programs/cme/opioid-based-pain-management-barriers-guidelines-and-best-practices/10086/ Chronic pain is clinically challenging for physicians to manage, in both primary care and specialty settings. Contributing to suboptimal outcomes of patients with chronic pain is the reluctance of physicians to prescribe opioid analgesics due to concerns with tolerance, dependence, addiction, and misuse/abuse. This...

Duration:00:14:59

The HPV Data Is In — What Do the Newest Updates in Screening Mean For Your Patients?

3/21/2018
More
CME credits: 0.50 Valid until: 22-03-2019 Claim your CME credit at https://reachmd.com/programs/cme/the-hpv-data-is-in-what-do-the-newest-updates-in-screening-mean-for-your-patients/10075/ The Cervical Cancer Screening practice environment continues to change for both physicians and patients. Physicians are constantly tasked with evaluating analyses of new data on how best to approach cervical cancer screening for a particular patient demographic; and patients remain confused and unsure...

Duration:00:25:00

Adnexal Mass Management: Risk Stratification and Management Practice for Best Patient Outcomes

2/27/2018
More
CME credits: 0.25 Valid until: 28-02-2020 Claim your CME credit at https://reachmd.com/programs/cme/adnexal-mass-management-risk-stratification-and-management-practice-best-patient-outcomes/10042/ Low awareness of women’s risk factors and symptoms for ovarian cancer, compounded by common use of diagnostic laboratory tests that are less sensitive and not specifically approved for assessing the risk of malignant adnexal mass, are the most important reasons that the great majority of women...

Duration:00:14:59

Diabetes and Cardiovascular Risk: New Thinking, New Opportunities

2/27/2018
More
CME credits: 0.50 Valid until: 27-02-2019 Claim your CME credit at https://reachmd.com/programs/cme/diabetes-and-cardiovascular-risk-new-thinking-new-opportunities/10007/ Diabetes is a major global health emergency, affecting approximately 415 million adults and contributing to five million deaths each year. Cardiovascular disease is a serious complication of type 2 diabetes mellitus (T2DM), contributing to the majority of morbidity and mortality in this population. In recent years, the...

Duration:00:28:29

Disease Modifying Therapies in MS: Highlights from ACTRIMS 2018

2/22/2018
More
CME credits: 0.25 Valid until: 23-02-2019 Claim your CME credit at https://reachmd.com/programs/cme/disease-modifying-therapies-ms-highlights-actrims-2018/10030/ Multiple sclerosis is a quickly advancing field of medicine. The data presented at the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) meeting heavily focused on new and emerging concepts, including immune cell populations in the pathophysiology of MS. Join Dr. Thomas Leist and Dr. Clyde Markowitz...

Duration:00:13:29

Overcoming Treatment Challenges for Tuberous Sclerosis Complex (TSC): SEGA and the Future of Seizure Management

2/15/2018
More
CME credits: 1.00 Valid until: 15-02-2019 Claim your CME credit at https://reachmd.com/programs/cme/overcoming-treatment-challenges-tuberous-sclerosis-complex-tsc-sega-and-future-seizure-management/9948/ Tuberous sclerosis complex (TSC) is an autosomal dominant genetic disorder characterized by the systemic growth of benign, noninvasive legions. SEGAs, which are slow-growing glioneural tumors that develop near the foramen of Monro, usually develop before the age of 20 years and...

Duration:00:50:51